title: Nonnociceptive afferent activity depresses nocifensive behavior and nociceptive synapses via an endocannabinoid-dependent mechanism.
abstract: Previously, low-frequency stimulation (LFS) of a nonnociceptive touch-sensitive neuron has been found to elicit endocannabinoid-dependent long-term depression (eCB-LTD) in nociceptive synapses in the leech central nervous system (CNS) that requires activation of a presynaptic transient receptor potential vanilloid (TRPV)-like receptor by postsynaptically synthesized 2-arachidonoyl glycerol (2-AG). This capacity of nonnociceptive afferent activity to reduce nociceptive signaling resembles gate control of pain, albeit longer lasting in these synaptic experiments. Since eCB-LTD has been observed at a single sensory-motor synapse, this study examines the functional relevance of this mechanism, specifically whether this form of synaptic plasticity has similar effects at the behavioral level in which additional, intersegmental neural circuits are engaged. Experiments were carried out using a semi-intact preparation that permitted both synaptic recordings and monitoring of the leech whole body shortening, a defensive withdrawal reflex that was elicited via intracellular stimulation of a single nociceptive neuron (the N cell). The same LFS of a nonnociceptive afferent that induced eCB-LTD in single synapses also produced an attenuation of the shortening reflex. Similar attenuation of behavior was also observed when 2-AG was applied. LFS-induced behavioral and synaptic depression was blocked by tetrahydrolipstatin (THL), a diacylglycerol lipase inhibitor, and by SB366791, a TRPV1 antagonist. The effects of both THL and SB366791 were observed following either bath application of the drug or intracellular injection into the presynaptic (SB366791) or postsynaptic (THL) neuron. These findings demonstrate a novel, endocannabinoid-based mechanism by which nonnociceptive afferent activity may modulate nocifensive behaviors via action on primary afferent synapses.
authors.affiliation: Center for Brain and Behavior Research, Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota.
authors.forename: Sharleen
authors.initials: S
authors.lastname: Yuan
authors.forename: Brian D
authors.initials: BD
authors.lastname: Burrell
mesh_terms: D000813:Anilides / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D063386:Cannabinoid Receptor Agonists / Q000494:pharmacology*; D002934:Cinnamates / Q000494:pharmacology; D063388:Endocannabinoids / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005989:Glycerides / Q000494:pharmacology*; D007783:Lactones / Q000494:pharmacology; D007865:Leeches; D036881:Long-Term Synaptic Depression; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology*; D059225:Nociception; D000077403:Orlistat; D012018:Reflex; D013569:Synapses / Q000187:drug effects / Q000502:physiology*; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors
chemical_list: D000813:Anilides; D001095:Arachidonic Acids; D063386:Cannabinoid Receptor Agonists; D002934:Cinnamates; D063388:Endocannabinoids; D004791:Enzyme Inhibitors; D005989:Glycerides; D007783:Lactones; C477659:N-(3-methoxyphenyl)-4-chlorocinnamanilide; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; C094503:glyceryl 2-arachidonate; D000077403:Orlistat
keywords: endocannabinoid; leech; long-term depression; nociception
references.citation: Prog Neurobiol. 2005 Aug;76(5):279-327
references.pmid: 16260077
references.citation: Nat Neurosci. 2010 Dec;13(12):1519-25
references.pmid: 21076424
references.citation: Curr Rheumatol Rep. 2008 Dec;10(6):492-9
references.pmid: 19007541
references.citation: Brain Behav Evol. 2009;74(3):206-18
references.pmid: 20029184
references.citation: J Physiol. 1974 Apr;238(2):357-69
references.pmid: 4366432
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):353-61
references.pmid: 12052049
references.citation: J Neurosci. 1997 Jan 15;17(2):786-95
references.pmid: 8987800
references.citation: J Pain. 2003 Apr;4(3):109-21
references.pmid: 14622708
references.citation: J Physiol. 2012 Oct 1;590(19):4717-33
references.pmid: 22826132
references.citation: Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3201-15
references.pmid: 23108540
references.citation: Brain Res. 2012 Jun 15;1460:1-11
references.pmid: 22578358
references.citation: Neuron. 2008 Mar 13;57(5):746-59
references.pmid: 18341994
references.citation: J Neurosci. 2008 Jul 9;28(28):7074-83
references.pmid: 18614676
references.citation: J Neurosci. 1998 Feb 15;18(4):1571-82
references.pmid: 9454862
references.citation: Learn Mem. 2011 Aug 15;18(9):545-53
references.pmid: 21844187
references.citation: Br J Anaesth. 2008 Jul;101(1):8-16
references.pmid: 18417503
references.citation: Mol Pain. 2006 Feb 17;2:8
references.pmid: 16503963
references.citation: Curr Med Chem. 2010;17(14):1430-49
references.pmid: 20166923
references.citation: Nature. 2005 Jun 23;435(7045):1108-12
references.pmid: 15973410
references.citation: J Biol Chem. 2001 Apr 20;276(16):12856-63
references.pmid: 11278420
references.citation: Nat Neurosci. 2010 Dec;13(12):1511-8
references.pmid: 21076423
references.citation: J Cell Biol. 2003 Nov 10;163(3):463-8
references.pmid: 14610053
references.citation: J Physiol. 1970 Aug;209(3):647-67
references.pmid: 5499801
references.citation: J Neurophysiol. 1968 Sep;31(5):740-56
references.pmid: 5711143
references.citation: J Neurosci. 2013 Mar 6;33(10):4349-58
references.pmid: 23467351
references.citation: J Neurosci. 2012 Jul 11;32(28):9457-68
references.pmid: 22787031
references.citation: Neurosci Lett. 2012 Feb 29;510(2):82-7
references.pmid: 22260796
references.citation: Neuron. 2008 Jun 26;58(6):884-96
references.pmid: 18579079
references.citation: J Physiol. 2009 Jun 1;587(Pt 11):2521-35
references.pmid: 19406878
references.citation: J Neurophysiol. 2010 Nov;104(5):2766-77
references.pmid: 20884761
references.citation: Dev Biol. 2006 Dec 1;300(1):434-60
references.pmid: 16965768
references.citation: J Neurophysiol. 1999 Sep;82(3):1114-23
references.pmid: 10482731
references.citation: J Neurosci. 1994 May;14(5 Pt 2):3280-92
references.pmid: 7910206
references.citation: J Neurobiol. 2004 Oct;61(1):161-74
references.pmid: 15362159
references.citation: Brain Res Mol Brain Res. 2001 Mar 5;87(2):145-59
references.pmid: 11245916
references.citation: J Comp Physiol A. 1995 Dec;177(6):667-81
references.pmid: 8537936
references.citation: Arch Phys Med Rehabil. 2006 Aug;87(8):1137-40
references.pmid: 16876561
references.citation: J Physiol. 2003 May 15;549(Pt 1):231-42
references.pmid: 12679376
references.citation: J Evol Biol. 2006 Mar;19(2):366-73
references.pmid: 16599912
references.citation: J Neurophysiol. 2001 Nov;86(5):2475-88
references.pmid: 11698536
references.citation: J Neuroimmune Pharmacol. 2010 Mar;5(1):103-21
references.pmid: 19847654
references.citation: Eur J Neurosci. 2009 May;29(10):1964-78
references.pmid: 19453631
references.citation: Brain Res. 1999 Jun 5;830(2):268-73
references.pmid: 10366683
references.citation: Annu Rev Neurosci. 2012;35:529-58
references.pmid: 22524785
references.citation: Brain Res Rev. 2009 Apr;60(1):149-70
references.pmid: 19167425
references.citation: Brain Res. 2008 Sep 4;1228:43-57
references.pmid: 18601913
references.citation: J Physiol. 1982 May;326:251-60
references.pmid: 7108790
references.citation: Neuron. 2007 Jun 7;54(5):801-12
references.pmid: 17553427
references.citation: J Neurophysiol. 1996 Jun;75(6):2268-79
references.pmid: 8793740
references.citation: J Neurophysiol. 2005 Dec;94(6):4002-10
references.pmid: 16120666
references.citation: Trends Pharmacol Sci. 2009 Aug;30(8):397-402
references.pmid: 19616317
references.citation: Science. 1965 Nov 19;150(3699):971-9
references.pmid: 5320816
references.citation: J Physiol. 1970 Aug;209(3):627-46
references.pmid: 5499800